Endpoint
Tumour response rate
CAT:outcome/tumour-response-ratereported in risk ratio
How it is measured
Proportion of patients achieving a complete or partial objective tumour response on imaging assessed against named criteria (WHO bidimensional or RECIST unidimensional). Criteria, assessment interval, and whether responses required confirmation recorded with each finding; WHO and RECIST are not interchangeable.
Measured, not recorded
- Subject
- tumour response rate
- Measurements
- 2 measurements
- Recorded as a finding
- No
Show what was measured
tumour response rate
no effect
(RR = 0.91, 0.78-1.06, P homogeneity = .33)
PMID:22542974 · one of two readings recorded this
tumour response rate
increases, n = 1185
Pooled analysis shows PARP inhibitors likely result in a moderate improvement in tumour response rate compared to other treatment arms (66.9% vs 48.9%; RR 1.39, 95% CI 1.24 to 1.54; 5 studies; 1185 participants; moderate-certainty evidence)
PMID:33886122 · one of two readings recorded this